SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Massimo Di Maio

Massimo Di Maio

University of Turin, Turin

Prof. Massimo Di Maio is Professor of Medical Oncology at the University of Turin and Director of Medical Oncology (Oncologia Medica 1) at AOU Città della Salute e della Scienza di Torino (Molinette) in Turin, Italy. His research centers on clinical trial methodology, meta-analyses of individual patient data, and patient-reported outcomes, with extensive work across thoracic and lung cancer. He serves as President of the Italian Association of Medical Oncology (AIOM), has authored more than 300 peer-reviewed publications, and holds editorial and guideline-development roles in oncology. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Massimo Di Maio

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates